Neoplasm
RecruitingStudy of MDNA11 Alone or with Pembrolizumab for Patients with Advanced Solid Tumors
- Disease:Neoplasm
- Substances:Mdna11Pembrolizumab
Spain- Participants:18–64 years · 65+ years
- Substances:Mdna11
- Sponsor:Medicenna Therapeutics Inc.
Rare diseases
Investigational molecules
Locations
Back to Spain597 clinical trials in Santander, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
Spain
SpainThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking trials focusing on metastatic colorectal cancer, mantle cell lymphoma, and gastrointestinal cancers. Studies evaluate novel combination therapies and targeted treatments for improved patient outcomes.
Multiple studies exploring new therapeutic approaches for various cancer types, including melanoma and lung cancer.
Clinical trials investigating treatments for chronic rhinosinusitis and uncontrolled asthma. Research focuses on developing innovative therapies and improving patient quality of life.
Studies evaluate both established and novel therapeutic approaches for respiratory conditions.
Innovative research examining treatments for psoriatic arthritis and Sjögren's disease. Trials focus on evaluating new biological therapies and their effectiveness in managing symptoms.
Comprehensive studies targeting various manifestations of autoimmune conditions.
Research investigating treatments for Alzheimer's disease and its connection with Down syndrome. Studies also include trials for multiple sclerosis and related neurological conditions.
Focused on developing effective treatments for complex neurological disorders.
Tell us about your condition – we search every trial in Europe and connect you with the right site.